A Bundled Intervention

Description

Opioid overdose deaths have reached historically high records in the United States and are particularly concentrated among patients after emergency department (ED) discharge. Evidence-based treatment modules to reduce repeat opioid overdose and mortality are lacking in this patient population. A bundled intervention is proposed, including telehealth, peer support specialist, buprenorphine, and linkage for definitive care, that is designed to increase treatment uptake in this patient population post-ED discharge, reduce repeat opioid overdoses, and end overdose deaths.

Conditions

Opioid Use Disorder, Opioid Overdose

Talk to us

Study Overview

On this page

Study Details

Study overview

Opioid overdose deaths have reached historically high records in the United States and are particularly concentrated among patients after emergency department (ED) discharge. Evidence-based treatment modules to reduce repeat opioid overdose and mortality are lacking in this patient population. A bundled intervention is proposed, including telehealth, peer support specialist, buprenorphine, and linkage for definitive care, that is designed to increase treatment uptake in this patient population post-ED discharge, reduce repeat opioid overdoses, and end overdose deaths.

A Bundled Intervention to End Opioid Overdose by Increasing Treatment Uptake Post Emergency Department Discharge

A Bundled Intervention

Condition
Opioid Use Disorder
Intervention / Treatment

-

Contacts and Locations

Birmingham

UAB, Birmingham, Alabama, United States, 35294

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. 19 years or older (the age of majority in Alabama);
  • 2. diagnosis of OUD and experiencing opioid overdose in the last 12 months;
  • 3. prescribed buprenorphine in the ED and willing to continue buprenorphine post-ED discharge;
  • 4. English speaking;
  • 5. not actively psychotic and suicidal, or cognitively impaired.
  • 6. Patients who are admitted to the hospital from the ED will be eligible for enrollment.
  • 1. living in a restricted environment (e.g., prison or jail facility, etc.);
  • 2. currently enrolled in other clinical studies;
  • 3. anticipated to take other prescribed opioids except buprenorphine for a medical condition longer than three months;
  • 4. known allergic reaction to buprenorphine;
  • 5. critically ill or injured;
  • 6. females with pregnancy (they are anticipated to request a higher level of care).

Ages Eligible for Study

19 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Alabama at Birmingham,

Li Li, MD;PhD, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

2030-11-30